[HTML][HTML] Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity …

…, M Kelson, R Schubert, C Friel, P Morgan-Jones… - Parkinsonism & Related …, 2022 - Elsevier
Introduction While physical activity (PA) is recognized as important in Huntington's disease (HD)
disease management, there has been no long-term evaluation undertaken. We aimed …

[HTML][HTML] Monitoring and managing lifestyle behaviors using wearable activity trackers: mixed methods study of views from the Huntington disease community

P Morgan-Jones, A Jones, M Busse, L Mills… - JMIR Formative …, 2022 - formative.jmir.org
Background There are early indications that lifestyle behaviors, specifically physical activity
and sleep, may be associated with the onset and progression of Huntington disease (HD). …

Wearable activity monitors to support physical activity interventions in neurodegenerative disease: a feasibility study

HJS Shih, L Quinn, P Morgan-Jones… - Neurodegenerative …, 2023 - Future Medicine
Aim: To evaluate the feasibility of using activity monitors in a physical activity (PA) intervention
in people with Parkinson's (PD) and Huntington's disease (HD). Materials & methods: …

Assessment of Fitbit Charge 4 for sleep stage and heart rate monitoring against polysomnography and during home monitoring in Huntington's disease

…, P Baumgartner, P Morgan-Jones… - Journal of Clinical …, 2024 - jcsm.aasm.org
Study Objectives: Wearable devices, monitoring sleep stages and heart rate (HR), bring the
potential for longitudinal sleep monitoring in patients with neurodegenerative diseases. …

Language-Independent Acoustic Biomarkers for Quantifying Speech Impairment in Huntington's Disease

…, J Krzysztofik, E Mann, P Morgan-Jones… - American Journal of …, 2024 - ASHA
Purpose: Changes in voice and speech are characteristic symptoms of Huntington's disease
(HD). Objective methods for quantifying speech impairment that can be used across …

Conducting focus groups in neurodegenerative disease populations: ethical and methodological considerations

A Jones, P Morgan-Jones, M Busse, V Shepherd… - BMJ open, 2021 - bmjopen.bmj.com
Background Involvement of vulnerable populations in research is critical to inform the
generalisability of evidence-based medicine to all groups of the population. Objective In this …

Utilization of wearable activity monitors to support physical activity interventions in neurodegenerative diseases: a feasibility study

HJS Shih, L Quinn, P Morgan-Jones, K Long… - medRxiv, 2022 - medrxiv.org
Purpose To evaluate the feasibility of using wearable activity monitors as part of a physical
activity (PA) intervention and describe patterns of device weartime and PA behavior in people …

[HTML][HTML] Objectively characterizing Huntington's disease using a novel upper limb dexterity test

S Woodgate, P Morgan-Jones, S Clinch, C Drew… - Journal of …, 2021 - Springer
Philippa Morgan-Jones: Financial disclosures related to research covered in this article:
Grants and Research: None. Susanne Clinch: Financial disclosures related to research covered …

F29 DOMINO-HD: A 12-month observational cohort study of lifestyle factors in people with huntington's disease

P Morgan-Jones, CJG Drew, L Mills, N Kirby… - 2021 - jnnp.bmj.com
Background The course of Huntington’s disease (HD) is believed to be modulated by lifestyle
and genetic factors. However, we do not understand how the interplay of these affects …

F33 Perceptions, motivators and barriers to the acceptance of wearable activity trackers in people with huntington's disease

P Morgan-Jones, A Jones, L Mills, P Pallmann… - 2021 - jnnp.bmj.com
Abstracts Page 1 for outcomes measures at baseline ranged from 42.3-100% and at 12 month
follow up from 19.2–85.2 %. Imbalances in pretreatment confounders for the cohort and …